Erik Stomrud

Lund University — Sweden

Medicine · Health Sciences

76h-index25.4kcitations437works14.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Dementia and Cognitive Impairment Research(297), Alzheimer's disease research and treatments(280), Functional Brain Connectivity Studies(70), Advanced Neuroimaging Techniques and Applications(49), Neurological Disease Mechanisms and Treatments(49)

Publications429 total

A minimally invasive dried blood spot biomarker test for the detection of Alzheimer’s disease pathology
Nature Medicine·2026· 3 citedOpen Access
Associations of modifiable and non-modifiable risk factors with longitudinal white matter hyperintensities, amyloid-β and tau - a prospective cohort study
The Journal of Prevention of Alzheimer s Disease·2026Open Access
Evaluation of the revised criteria for biological and clinical staging of Alzheimer's disease
Alzheimer s & Dementia·2025Open Access
Disease timeline modelling of amyloid and tau PET reveals dynamic timescales of amyloid and tau accumulation in Alzheimer's disease
Alzheimer s & Dementia·2025Open Access
Quantitation of PET spatial extent as a potential adjunct to visual interpretation of [ <sup>18</sup> F]flortaucipir imaging
Alzheimer s & Dementia·2025Open Access
Discriminating AD Biomarker Groups Based on a Digital Speech Biomarker for Cognition (SB‐C)
Alzheimer s & Dementia·2025Open Access
Hemispheric Asymmetry of Amyloid Deposition Influences Asymmetric Tau Pathology in Alzheimer’s Disease
Alzheimer s & Dementia·2025Open Access
ABIDEing with automated cerebrospinal fluid assays; update of an MCI to dementia prediction model
Alzheimer s & Dementia·2025Open Access
<i>APOE ε4</i> ‐related proteomic profiles in plasma and CSF
Alzheimer s & Dementia·2025Open Access
Biological staging of Alzheimer’s disease with the novel plasma eMTBR‐tau243 and % <i>p</i> ‐tau217
Alzheimer s & Dementia·2025Open Access
Reference proteins to improve performance of core 1 and core 2 Alzheimer's disease CSF and plasma biomarkers
Alzheimer s & Dementia·2025Open Access
Longitudinal tau‐PET accumulation and downstream effects in amyloid‐beta negative cognitively unimpaired individuals
Alzheimer s & Dementia·2025Open Access
Predicting cognitive decline in amyloid‐negative individuals with amnestic mild cognitive impairment
Alzheimer s & Dementia·2025Open Access
Prediction of progression to dementia in individuals with subjective cognitive decline
Alzheimer s & Dementia·2025Open Access
Brain connectivity drives tau presence while regional vulnerability drives tau load in Alzheimer's disease
Alzheimer s & Dementia·2025Open Access
Individual functional connectivity constraints on spatial progression of tau pathology in Alzheimer's disease
Alzheimer s & Dementia·2025Open Access
Clinical performance of blood biomarkers across settings and countries
Alzheimer s & Dementia·2025Open Access
Clinical usefulness of plasma <i>p</i> ‐tau217 and eMTBR‐tau243 combination for diagnosis and patient stratification
Alzheimer s & Dementia·2025Open Access
Predicting cognitive decline in amyloid‐negative individuals with amnestic mild cognitive impairment
Alzheimer s & Dementia·2025Open Access
Disease timeline modelling of amyloid and tau PET reveals dynamic timescales of amyloid and tau accumulation in Alzheimer’s disease
Alzheimer s & Dementia·2025Open Access
page 1 of 22Next →

Frequent Co-authors

Oskar Hansson(49), Niklas Mattsson(41), Sebastian Palmqvist(40), Kaj Blennow(30), Henrik Zetterberg(26), Shorena Janelidze(22), Ruben Smith(15), Shorena Janelidze(15), Jeffrey L. Dage(14), Olof Strandberg(13), Rik Ossenkoppele(9), Antoine Leuzy(8), Nicholas Cullen(8), Nicholas J. Ashton(7), Danielle van Westen(7), Udo Eichenlaub(6), Philip S. Insel(6), Randall J. Bateman(6), Xiyun Chai(5), Nicholas K. Proctor(5)